US 7585842
Human kunitz-type inhibitor with enhanced antifibrinolytic activity
granted A61KA61K38/00A61P
Quick answer
US patent 7585842 (Human kunitz-type inhibitor with enhanced antifibrinolytic activity) held by The Regents of the University of California expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61P, A61P11/06, A61P29/00